A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy
Spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's disease) is one of nine neurodegenerative disorders that are caused by expansion of polyglutamine-encoding CAG repeats. Intracellular accumulation of abnormal proteins in these diseases, a pathological hallmark, is associated wit...
Saved in:
Published in | Human molecular genetics Vol. 25; no. 10; pp. 1979 - 1989 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
15.05.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's disease) is one of nine neurodegenerative disorders that are caused by expansion of polyglutamine-encoding CAG repeats. Intracellular accumulation of abnormal proteins in these diseases, a pathological hallmark, is associated with defects in protein homeostasis. Enhancement of the cellular proteostasis capacity with small molecules has therefore emerged as a promising approach to treatment. Here, we characterize a novel curcumin analog, ASC-JM17, as an activator of central pathways controlling protein folding, degradation and oxidative stress resistance. ASC-JM17 acts on Nrf1, Nrf2 and Hsf1 to increase the expression of proteasome subunits, antioxidant enzymes and molecular chaperones. We show that ASC-JM17 ameliorates toxicity of the mutant androgen receptor (AR) responsible for SBMA in cell, fly and mouse models. Knockdown of the Drosophila Nrf1 and Nrf2 ortholog cap 'n' collar isoform-C, but not Hsf1, blocks the protective effect of ASC-JM17 on mutant AR-induced eye degeneration in flies. Our observations indicate that activation of the Nrf1/Nrf2 pathway is a viable option for pharmacological intervention in SBMA and potentially other polyglutamine diseases. |
---|---|
AbstractList | Spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's disease) is one of nine neurodegenerative disorders that are caused by expansion of polyglutamine-encoding CAG repeats. Intracellular accumulation of abnormal proteins in these diseases, a pathological hallmark, is associated with defects in protein homeostasis. Enhancement of the cellular proteostasis capacity with small molecules has therefore emerged as a promising approach to treatment. Here, we characterize a novel curcumin analog, ASC-JM17, as an activator of central pathways controlling protein folding, degradation and oxidative stress resistance. ASC-JM17 acts on Nrf1, Nrf2 and Hsf1 to increase the expression of proteasome subunits, antioxidant enzymes and molecular chaperones. We show that ASC-JM17 ameliorates toxicity of the mutant androgen receptor (AR) responsible for SBMA in cell, fly and mouse models. Knockdown of the
Drosophila
Nrf1 and Nrf2 ortholog cap ‘n’ collar isoform-C, but not Hsf1, blocks the protective effect of ASC-JM17 on mutant AR-induced eye degeneration in flies. Our observations indicate that activation of the Nrf1/Nrf2 pathway is a viable option for pharmacological intervention in SBMA and potentially other polyglutamine diseases. Spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's disease) is one of nine neurodegenerative disorders that are caused by expansion of polyglutamine-encoding CAG repeats. Intracellular accumulation of abnormal proteins in these diseases, a pathological hallmark, is associated with defects in protein homeostasis. Enhancement of the cellular proteostasis capacity with small molecules has therefore emerged as a promising approach to treatment. Here, we characterize a novel curcumin analog, ASC-JM17, as an activator of central pathways controlling protein folding, degradation and oxidative stress resistance. ASC-JM17 acts on Nrf1, Nrf2 and Hsf1 to increase the expression of proteasome subunits, antioxidant enzymes and molecular chaperones. We show that ASC-JM17 ameliorates toxicity of the mutant androgen receptor (AR) responsible for SBMA in cell, fly and mouse models. Knockdown of the Drosophila Nrf1 and Nrf2 ortholog cap 'n' collar isoform-C, but not Hsf1, blocks the protective effect of ASC-JM17 on mutant AR-induced eye degeneration in flies. Our observations indicate that activation of the Nrf1/Nrf2 pathway is a viable option for pharmacological intervention in SBMA and potentially other polyglutamine diseases. |
Author | Dantuma, Nico P Shih, Charles C-Y Fischbeck, Kenneth H Bott, Laura C Katsuno, Masahisa Chen, Ke-Lian Sobue, Gen Harmison, George G Bautista, Elaine Rinaldi, Carlo Badders, Nisha M Taylor, J Paul |
Author_xml | – sequence: 1 givenname: Laura C surname: Bott fullname: Bott, Laura C email: laura.bott@northwestern.edu organization: Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA, Department of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden, laura.bott@northwestern.edu – sequence: 2 givenname: Nisha M surname: Badders fullname: Badders, Nisha M organization: Department of Cell and Molecular Biology, St Jude Children's Research Hospital, Memphis, TN 38105, USA – sequence: 3 givenname: Ke-Lian surname: Chen fullname: Chen, Ke-Lian organization: Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA – sequence: 4 givenname: George G surname: Harmison fullname: Harmison, George G organization: Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA – sequence: 5 givenname: Elaine surname: Bautista fullname: Bautista, Elaine organization: Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA – sequence: 6 givenname: Charles C-Y surname: Shih fullname: Shih, Charles C-Y organization: AndroScience Corporation, Solana Beach, CA 92075, USA and – sequence: 7 givenname: Masahisa surname: Katsuno fullname: Katsuno, Masahisa organization: Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan – sequence: 8 givenname: Gen surname: Sobue fullname: Sobue, Gen organization: Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan – sequence: 9 givenname: J Paul surname: Taylor fullname: Taylor, J Paul organization: Department of Cell and Molecular Biology, St Jude Children's Research Hospital, Memphis, TN 38105, USA – sequence: 10 givenname: Nico P surname: Dantuma fullname: Dantuma, Nico P organization: Department of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden – sequence: 11 givenname: Kenneth H surname: Fischbeck fullname: Fischbeck, Kenneth H organization: Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA – sequence: 12 givenname: Carlo surname: Rinaldi fullname: Rinaldi, Carlo organization: Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26962150$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:134496629$$DView record from Swedish Publication Index |
BookMark | eNpVkV1vFCEYhYmpsdvqjT_AcGlMxvI1zHBj0jR-JY3e6DV5h2F2UQZGYFr338u6a2MvCCdwzsNLzgU6CzFYhF5S8pYSxa928_ZqHO9Jx5-gDRWSNIz0_AxtiJKikYrIc3SR8w9CqBS8e4bOmVSS0ZZsULzGeQbvmzl6a1Zv8Zc0UQxhPAiGwRR3ByUmPLvitlBsxkv0-61fC8wuWFzib2dc2WMXcF5cAP83Pax-gJpac6VWASXFZbd_jp5O4LN9cdov0fcP77_dfGpuv378fHN92xihRGmUHWjXCsGZmBih3LbS0h7kCKYn3DDDh74fRyMlBavaAcQkBsVFTyZBoJv4JVJHbr63yzroJbkZ0l5HcFXHUZ_Of7rD0tlqyoVQUjJVs--O2WqY7WhsKAn8Y8Sjm-B2ehvvdEska_uuAl6fACn-Wm0uenbZWO8h2LhmTXsm6-T1h9X65mg1Keac7PTwDCX60K6u7epju9X86v_BHqz_6uR_ALfJps0 |
CitedBy_id | crossref_primary_10_1016_j_redox_2023_103003 crossref_primary_10_1172_JCI99042 crossref_primary_10_1038_nm_4500 crossref_primary_10_1083_jcb_201612111 crossref_primary_10_1126_sciadv_abi6896 crossref_primary_10_17352_2455_8605_000045 crossref_primary_10_3389_fnmol_2016_00164 crossref_primary_10_1080_15548627_2016_1208889 crossref_primary_10_17352_2455_8605_000044 crossref_primary_10_1016_j_redox_2023_102819 crossref_primary_10_1016_j_neuroscience_2019_02_020 crossref_primary_10_3389_fnmol_2022_1020143 crossref_primary_10_1111_febs_14379 crossref_primary_10_1515_bmc_2022_0018 crossref_primary_10_3389_fmolb_2019_00048 crossref_primary_10_3390_ijms21103683 crossref_primary_10_18632_aging_101804 crossref_primary_10_1016_j_redox_2017_01_006 crossref_primary_10_3390_antiox11071389 crossref_primary_10_1038_s41598_019_40118_3 crossref_primary_10_3389_fphar_2024_1348076 crossref_primary_10_1016_j_redox_2019_101413 crossref_primary_10_1080_10409238_2020_1841726 crossref_primary_10_3390_biology12091169 crossref_primary_10_1016_j_cell_2019_03_035 crossref_primary_10_1007_s13311_018_0606_7 crossref_primary_10_1016_j_nmd_2019_07_008 crossref_primary_10_1016_j_taap_2018_09_037 crossref_primary_10_1080_21678707_2017_1329088 crossref_primary_10_3390_biom10050702 crossref_primary_10_1016_j_isci_2023_107375 crossref_primary_10_1097_WCO_0000000000000856 crossref_primary_10_1002_jnr_25278 crossref_primary_10_3389_fnmol_2022_931301 crossref_primary_10_1155_2020_3129497 crossref_primary_10_1016_j_nmd_2024_03_003 crossref_primary_10_1007_s40620_022_01484_w crossref_primary_10_1016_j_critrevonc_2023_104142 crossref_primary_10_7554_eLife_44425 crossref_primary_10_1021_acs_joc_2c01357 crossref_primary_10_3390_antiox13060649 crossref_primary_10_3390_pharmaceutics15010212 crossref_primary_10_4103_JCRP_JCRP_11_21 crossref_primary_10_1016_j_expneurol_2024_114741 crossref_primary_10_1074_jbc_R118_003237 crossref_primary_10_1038_s41419_021_03441_0 crossref_primary_10_1155_2020_1269624 crossref_primary_10_1016_j_coph_2023_102394 |
Cites_doi | 10.2119/molmed.2012.00271 10.1038/nature09299 10.1111/jnc.12647 10.1038/352077a0 10.1073/pnas.0506249102 10.1021/jm020200g 10.2353/ajpath.2007.060898 10.1038/nature11315 10.1146/annurev.pharmtox.46.120604.141046 10.1016/j.neuron.2010.08.034 10.1093/hmg/11.5.515 10.1038/nchembio.1140 10.1155/2014/174282 10.1093/hmg/10.12.1307 10.1038/nphys2194 10.1016/j.molcel.2010.02.029 10.1016/j.cub.2014.06.004 10.1074/jbc.M709347200 10.1074/jbc.C113.481945 10.1093/emboj/17.6.1779 10.1093/hmg/11.9.1137 10.1042/BJ20060725 10.1242/dmm.007575 10.1523/JNEUROSCI.4099-08.2008 10.1128/MCB.00799-10 10.7554/eLife.01856 10.1146/annurev.neuro.29.051605.113042 10.1371/journal.pone.0016172 10.1093/hmg/ddn419 10.1016/S1097-2765(04)00151-0 10.1093/hmg/11.17.1967 10.1146/annurev.biochem.67.1.425 10.1016/j.neuron.2009.07.019 10.1101/gad.11.6.786 10.1126/science.1141448 10.1242/dmm.003301 10.1096/fj00-0294rev 10.1073/pnas.93.24.13943 10.1146/annurev-pharmtox-010814-124332 10.1371/journal.pone.0057932 10.1038/nm1298 10.1074/jbc.275.12.8772 10.1038/nm1547 10.1523/JNEUROSCI.23-06-02203.2003 10.1038/nature09873 10.1016/S0896-6273(02)00834-6 10.1016/j.nmd.2014.06.441 10.1523/JNEUROSCI.3032-06.2006 10.1038/ncomms2417 10.1093/brain/aws343 10.1093/hmg/ddn310 |
ContentType | Journal Article |
Copyright | Published by Oxford University Press 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US. Published by Oxford University Press 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2016 |
Copyright_xml | – notice: Published by Oxford University Press 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US. – notice: Published by Oxford University Press 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2016 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM ADTPV AOWAS D8T ZZAVC |
DOI | 10.1093/hmg/ddw073 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Freely available online SwePub Articles full text |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1460-2083 |
EndPage | 1989 |
ExternalDocumentID | oai_prod_swepub_kib_ki_se_134496629 10_1093_hmg_ddw073 26962150 |
Genre | Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Intramural NIH HHS grantid: ZIA NS003038-10 – fundername: NINDS NIH HHS grantid: U01 NS069515 – fundername: NINDS NIH HHS grantid: R01 NS053825 – fundername: NIH grantid: 1ZIA NS003038 – fundername: NINDS – fundername: KI-NIH Graduate Partnership Program in Neuroscience – fundername: NIH grantid: U01NS069515; NS053825 – fundername: Swedish Research Council – fundername: Association Française contre les Myopathies (AFM) Telethon |
GroupedDBID | --- -DZ -E4 .2P .I3 .XZ .ZR 0R~ 18M 1TH 29I 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP AAVLN ABEUO ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPTD ABQLI ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTO ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFXEN AGINJ AGKEF AGQXC AGSYK AHMBA AHXPO AIAGR AIJHB AJEEA AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ARIXL ATGXG AXUDD AYOIW BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM C45 CDBKE CGR CS3 CUY CVF CZ4 DAKXR DIK DILTD DU5 D~K EBS ECM EE~ EIF EJD EMOBN F5P F9B FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IH2 IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M49 ML0 N9A NGC NLBLG NOMLY NOYVH NPM NU- NVLIB O9- OAWHX OBC OBOKY OBS OCZFY ODMLO OEB OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 RIG ROL ROX ROZ RUSNO RW1 RXO SJN TEORI TJX TLC TMA TR2 W8F WOQ X7H XSW YAYTL YKOAZ YXANX ZKX ~91 AAYXX CITATION 7X8 ABSAR 5PM .55 .GJ 6.Y AAPGJ AAWDT AAYOK ABEFU ABQTQ ABSMQ ABTAH ACFRR ACPQN ACUTJ ACZBC ADTPV AEHUL AEKPW AFFNX AFSHK AFYAG AGKRT AGMDO ANFBD AOWAS APJGH AQDSO AQKUS ASAOO ASPBG ATDFG ATTQO AVNTJ AVWKF AZFZN BZKNY C1A CAG COF CXTWN D8T DFGAJ EIHJH ELUNK FEDTE HVGLF MBLQV MBTAY NEJ NTWIH O0~ O~Y PB- QBD RNI RZF RZO TCN X7M ZCG ZGI ZXP ZY4 ZZAVC |
ID | FETCH-LOGICAL-c494t-9eb17544324f2013e56e18a6dac803c2c3b88ddc661ae95ba4f4b93480f40a7f3 |
ISSN | 0964-6906 1460-2083 |
IngestDate | Wed Oct 09 03:36:03 EDT 2024 Tue Sep 17 20:55:38 EDT 2024 Tue Aug 27 04:56:07 EDT 2024 Thu Sep 12 19:09:57 EDT 2024 Sat Sep 28 08:47:57 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | Published by Oxford University Press 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c494t-9eb17544324f2013e56e18a6dac803c2c3b88ddc661ae95ba4f4b93480f40a7f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK. Present address: Department of Molecular Biosciences, Rice Institute for Biomedical Research, Northwestern University, Evanston, IL 60208, USA. |
OpenAccessLink | http://kipublications.ki.se/Default.aspx?queryparsed=id:134496629 |
PMID | 26962150 |
PQID | 1826661175 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | swepub_primary_oai_prod_swepub_kib_ki_se_134496629 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5062587 proquest_miscellaneous_1826661175 crossref_primary_10_1093_hmg_ddw073 pubmed_primary_26962150 |
PublicationCentury | 2000 |
PublicationDate | 2016-05-15 |
PublicationDateYYYYMMDD | 2016-05-15 |
PublicationDate_xml | – month: 05 year: 2016 text: 2016-05-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Human molecular genetics |
PublicationTitleAlternate | Hum Mol Genet |
PublicationYear | 2016 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | 16260738 - Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16801-6 17334372 - Nat Med. 2007 Mar;13(3):348-53 16968214 - Annu Rev Pharmacol Toxicol. 2007;47:89-116 19074031 - J Neurosci. 2008 Dec 10;28(50):13574-81 22952056 - Mol Med. 2012 Dec 06;18:1261-8 18276881 - Science. 2008 Feb 15;319(5865):916-9 23839939 - J Biol Chem. 2013 Aug 16;288(33):23633-8 2062380 - Nature. 1991 Jul 4;352(6330):77-9 21719443 - Dis Model Mech. 2011 Sep;4(5):701-7 10722721 - J Biol Chem. 2000 Mar 24;275(12):8772-8 19692580 - Dis Model Mech. 2009 Sep-Oct;2(9-10):500-7 18824496 - Hum Mol Genet. 2009 Jan 1;18(1):27-42 16872277 - Biochem J. 2006 Nov 1;399(3):373-85 24578620 - ScientificWorldJournal. 2014 Jan 22;2014:174282 12657679 - J Neurosci. 2003 Mar 15;23(6):2203-11 8943040 - Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13943-8 17525273 - Am J Pathol. 2007 Jun;170(6):2068-76 17417937 - Annu Rev Neurosci. 2007;30:575-621 25047668 - Neuromuscul Disord. 2014 Nov;24(11):978-81 9087432 - Genes Dev. 1997 Mar 15;11(6):786-98 20869592 - Neuron. 2010 Sep 23;67(6):936-52 24383989 - J Neurochem. 2014 May;129(3):539-47 21451522 - Nature. 2011 Apr 14;472(7342):226-9 19066230 - Hum Mol Genet. 2009 Mar 1;18(5):898-910 11406612 - Hum Mol Genet. 2001 Jun 1;10 (12 ):1307-15 11978772 - Hum Mol Genet. 2002 May 1;11(9):1137-51 11875046 - Hum Mol Genet. 2002 Mar 1;11(5):515-23 11344080 - FASEB J. 2001 May;15(7):1118-31 12165558 - Hum Mol Genet. 2002 Aug 15;11(17):1967-76 12372280 - Neuron. 2002 Aug 29;35(5):843-54 18343811 - J Biol Chem. 2008 May 9;283(19):12919-25 15068806 - Mol Cell. 2004 Apr 9;14(1):95-104 24448410 - Elife. 2014;3:e01856 21297955 - PLoS One. 2011 Jan 31;6(1):e16172 22922647 - Nature. 2012 Sep 13;489(7415):263-8 23222885 - Nat Chem Biol. 2013 Feb;9(2):112-8 9501099 - EMBO J. 1998 Mar 16;17(6):1779-87 12408714 - J Med Chem. 2002 Nov 7;45(23):5037-42 24998528 - Curr Biol. 2014 Jul 21;24(14 ):1573-83 21149573 - Mol Cell Biol. 2011 Feb;31(4):897-909 19679072 - Neuron. 2009 Aug 13;63(3):316-28 16155577 - Nat Med. 2005 Oct;11(10):1088-95 20385086 - Mol Cell. 2010 Apr 9;38(1):17-28 20829789 - Nature. 2010 Sep 9;467(7312):179-84 17122035 - J Neurosci. 2006 Nov 22;26(47):12106-17 22198733 - Nat Chem Biol. 2011 Dec 25;8(2):185-96 23469253 - PLoS One. 2013;8(3):e57932 25292434 - Annu Rev Pharmacol Toxicol. 2015 ;55:353-71 9759494 - Annu Rev Biochem. 1998;67:425-79 23393146 - Brain. 2013 Mar;136(Pt 3):926-43 23360996 - Nat Commun. 2013;4:1405 Wang (2016101302472961000_25.10.1979.34) 2013; 9 2016101302472961000_25.10.1979.21 2016101302472961000_25.10.1979.20 2016101302472961000_25.10.1979.23 2016101302472961000_25.10.1979.22 2016101302472961000_25.10.1979.25 2016101302472961000_25.10.1979.27 2016101302472961000_25.10.1979.26 2016101302472961000_25.10.1979.29 2016101302472961000_25.10.1979.28 2016101302472961000_25.10.1979.30 2016101302472961000_25.10.1979.32 2016101302472961000_25.10.1979.31 2016101302472961000_25.10.1979.33 2016101302472961000_25.10.1979.36 Adachi (2016101302472961000_25.10.1979.9) 2003; 23 2016101302472961000_25.10.1979.35 2016101302472961000_25.10.1979.38 2016101302472961000_25.10.1979.37 2016101302472961000_25.10.1979.39 Brondino (2016101302472961000_25.10.1979.24) 2014; 2014 2016101302472961000_25.10.1979.6 2016101302472961000_25.10.1979.7 2016101302472961000_25.10.1979.8 2016101302472961000_25.10.1979.41 2016101302472961000_25.10.1979.1 2016101302472961000_25.10.1979.40 2016101302472961000_25.10.1979.2 2016101302472961000_25.10.1979.43 2016101302472961000_25.10.1979.3 2016101302472961000_25.10.1979.42 2016101302472961000_25.10.1979.4 2016101302472961000_25.10.1979.45 2016101302472961000_25.10.1979.5 2016101302472961000_25.10.1979.44 2016101302472961000_25.10.1979.47 2016101302472961000_25.10.1979.46 2016101302472961000_25.10.1979.49 2016101302472961000_25.10.1979.48 2016101302472961000_25.10.1979.50 2016101302472961000_25.10.1979.51 2016101302472961000_25.10.1979.10 2016101302472961000_25.10.1979.12 2016101302472961000_25.10.1979.11 2016101302472961000_25.10.1979.14 2016101302472961000_25.10.1979.13 2016101302472961000_25.10.1979.16 2016101302472961000_25.10.1979.15 2016101302472961000_25.10.1979.18 2016101302472961000_25.10.1979.17 2016101302472961000_25.10.1979.19 |
References_xml | – ident: 2016101302472961000_25.10.1979.51 doi: 10.2119/molmed.2012.00271 – ident: 2016101302472961000_25.10.1979.46 doi: 10.1038/nature09299 – ident: 2016101302472961000_25.10.1979.49 doi: 10.1111/jnc.12647 – ident: 2016101302472961000_25.10.1979.2 doi: 10.1038/352077a0 – ident: 2016101302472961000_25.10.1979.36 doi: 10.1073/pnas.0506249102 – ident: 2016101302472961000_25.10.1979.25 doi: 10.1021/jm020200g – ident: 2016101302472961000_25.10.1979.44 doi: 10.2353/ajpath.2007.060898 – ident: 2016101302472961000_25.10.1979.45 doi: 10.1038/nature11315 – ident: 2016101302472961000_25.10.1979.13 doi: 10.1146/annurev.pharmtox.46.120604.141046 – ident: 2016101302472961000_25.10.1979.27 doi: 10.1016/j.neuron.2010.08.034 – ident: 2016101302472961000_25.10.1979.10 doi: 10.1093/hmg/11.5.515 – volume: 9 start-page: 112 year: 2013 ident: 2016101302472961000_25.10.1979.34 article-title: Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.1140 contributor: fullname: Wang – volume: 2014 start-page: 174282 year: 2014 ident: 2016101302472961000_25.10.1979.24 article-title: Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies publication-title: Sci. World J. doi: 10.1155/2014/174282 contributor: fullname: Brondino – ident: 2016101302472961000_25.10.1979.35 doi: 10.1093/hmg/10.12.1307 – ident: 2016101302472961000_25.10.1979.23 doi: 10.1038/nphys2194 – ident: 2016101302472961000_25.10.1979.14 doi: 10.1016/j.molcel.2010.02.029 – ident: 2016101302472961000_25.10.1979.15 doi: 10.1016/j.cub.2014.06.004 – ident: 2016101302472961000_25.10.1979.18 doi: 10.1074/jbc.M709347200 – ident: 2016101302472961000_25.10.1979.39 doi: 10.1074/jbc.C113.481945 – ident: 2016101302472961000_25.10.1979.41 doi: 10.1093/emboj/17.6.1779 – ident: 2016101302472961000_25.10.1979.12 doi: 10.1093/hmg/11.9.1137 – ident: 2016101302472961000_25.10.1979.30 doi: 10.1042/BJ20060725 – ident: 2016101302472961000_25.10.1979.40 doi: 10.1242/dmm.007575 – ident: 2016101302472961000_25.10.1979.47 doi: 10.1523/JNEUROSCI.4099-08.2008 – ident: 2016101302472961000_25.10.1979.32 doi: 10.1128/MCB.00799-10 – ident: 2016101302472961000_25.10.1979.31 doi: 10.7554/eLife.01856 – ident: 2016101302472961000_25.10.1979.1 doi: 10.1146/annurev.neuro.29.051605.113042 – ident: 2016101302472961000_25.10.1979.50 doi: 10.1371/journal.pone.0016172 – ident: 2016101302472961000_25.10.1979.20 doi: 10.1093/hmg/ddn419 – ident: 2016101302472961000_25.10.1979.17 doi: 10.1016/S1097-2765(04)00151-0 – ident: 2016101302472961000_25.10.1979.3 doi: 10.1093/hmg/11.17.1967 – ident: 2016101302472961000_25.10.1979.16 doi: 10.1146/annurev.biochem.67.1.425 – ident: 2016101302472961000_25.10.1979.19 doi: 10.1016/j.neuron.2009.07.019 – ident: 2016101302472961000_25.10.1979.42 doi: 10.1101/gad.11.6.786 – ident: 2016101302472961000_25.10.1979.7 doi: 10.1126/science.1141448 – ident: 2016101302472961000_25.10.1979.6 doi: 10.1242/dmm.003301 – ident: 2016101302472961000_25.10.1979.8 doi: 10.1096/fj00-0294rev – ident: 2016101302472961000_25.10.1979.43 doi: 10.1073/pnas.93.24.13943 – ident: 2016101302472961000_25.10.1979.33 doi: 10.1146/annurev-pharmtox-010814-124332 – ident: 2016101302472961000_25.10.1979.48 doi: 10.1371/journal.pone.0057932 – ident: 2016101302472961000_25.10.1979.21 doi: 10.1038/nm1298 – ident: 2016101302472961000_25.10.1979.11 doi: 10.1074/jbc.275.12.8772 – ident: 2016101302472961000_25.10.1979.28 doi: 10.1038/nm1547 – volume: 23 start-page: 2203 year: 2003 ident: 2016101302472961000_25.10.1979.9 article-title: Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.23-06-02203.2003 contributor: fullname: Adachi – ident: 2016101302472961000_25.10.1979.22 doi: 10.1038/nature09873 – ident: 2016101302472961000_25.10.1979.26 doi: 10.1016/S0896-6273(02)00834-6 – ident: 2016101302472961000_25.10.1979.29 doi: 10.1016/j.nmd.2014.06.441 – ident: 2016101302472961000_25.10.1979.4 doi: 10.1523/JNEUROSCI.3032-06.2006 – ident: 2016101302472961000_25.10.1979.38 doi: 10.1038/ncomms2417 – ident: 2016101302472961000_25.10.1979.37 doi: 10.1093/brain/aws343 – ident: 2016101302472961000_25.10.1979.5 doi: 10.1093/hmg/ddn310 |
SSID | ssj0016437 |
Score | 2.4630828 |
Snippet | Spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's disease) is one of nine neurodegenerative disorders that are caused by expansion of... |
SourceID | swepub pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1979 |
SubjectTerms | Animals Bulbo-Spinal Atrophy, X-Linked - drug therapy Bulbo-Spinal Atrophy, X-Linked - genetics Bulbo-Spinal Atrophy, X-Linked - pathology Curcumin - administration & dosage Curcumin - analogs & derivatives Curcumin - chemistry Disease Models, Animal DNA-Binding Proteins - genetics Drosophila melanogaster - genetics Drosophila Proteins - genetics Gene Knockdown Techniques Heat Shock Transcription Factors Humans Medicin och hälsovetenskap Mice Muscular Disorders, Atrophic - drug therapy Muscular Disorders, Atrophic - genetics Muscular Disorders, Atrophic - pathology NF-E2-Related Factor 1 - genetics NF-E2-Related Factor 2 - genetics Oxidative Stress - drug effects Peptides - genetics Proteasome Endopeptidase Complex - drug effects Protein Aggregation, Pathological - genetics Protein Folding - drug effects Receptors, Androgen - genetics Signal Transduction - drug effects Small Molecule Libraries - administration & dosage Transcription Factors - genetics Trinucleotide Repeat Expansion - genetics |
Title | A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26962150 https://search.proquest.com/docview/1826661175 https://pubmed.ncbi.nlm.nih.gov/PMC5062587 http://kipublications.ki.se/Default.aspx?queryparsed=id:134496629 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEIgXBOOrfMkI3qJsTuI4yWNVGIWpEw-btLfISRwa0aTV0gLjj-Nv4y520kSbEOyhkeXUsZv71T6f735HyDseijxwnNzOMpbaPAgxGyBXNhcydZNQKtakTpifiNkZ_3zun49Gv3teS9tNcpD-ujau5CZShTqQK0bJ_odku4dCBZRBvnAFCcP1n2Q8sepSLpd2qXPcKuvkInea4wAouA1PxnfcVFtl0VBpqBqTMlx-hTHJEtXLzepnkaIeXlRWvW4SZGHrZLtMJLTaGi9VtJe3tNZGkdXG_7JNrouZmDEccmd0N44gGHctrenBzmKKlCW1BmG9kNa8uzU1gSLHyl72QDuTiEXtHKAt-NbHg76xwhF4zq7DNf8WBNm3SgpuI3eyXp70nMwFA7HrfDftpK2jpVtwst4U7EQ6O41ZztEn7NqlQtNoLUqYUY-y7AfTGVV6qFmXDWxcEQnQi9huwWydBL7Mpz6D_WMY3CK33SDycfP__tNxd4qFh6IN16P5US09buQdQr-HulekozZdDHWjKxueq367A3bbRiM6fUDum60MnWhcPiQjVe2TOzq56eU-uTs3bhuPyGpCh0ClCFQKUMOCSzug0g6odABU2gKVFhXVQG1aa6DSFqjUAPUxOTv6cDqd2SbTh53yiG_sCDSGhonR5bmLhnlfKCeUIpNpyLzUTb0kDLMsBWVSqshPJM95Enk8ZDlnMsi9J2SvWlXqGaGpcEOlfD-DRlzhsXqWMyV8ULu8hPFkTN627zhea0KXWDtieDEIJdZCGZM37euPAeN4iCYrtdrWMe7HYRgw3DF5qsXRPaeV45gEA0F1X0Au9-Gdqlg0nO4GSGPiapEOm4AuFZv6bwV-4lrFjsd5JIQbPb9xdy_Ivd2_9CXZ21xs1StQsjfJ6wbJfwCHn9qj |
link.rule.ids | 230,315,786,790,891,27957,27958 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+small-molecule+Nrf1+and+Nrf2+activator+mitigates+polyglutamine+toxicity+in+spinal+and+bulbar+muscular+atrophy&rft.jtitle=Human+molecular+genetics&rft.au=Bott%2C+Laura+C.&rft.au=Badders%2C+Nisha+M.&rft.au=Chen%2C+Ke-lian&rft.au=Harmison%2C+George+G.&rft.date=2016-05-15&rft.pub=Oxford+University+Press&rft.issn=0964-6906&rft.eissn=1460-2083&rft.volume=25&rft.issue=10&rft.spage=1979&rft.epage=1989&rft_id=info:doi/10.1093%2Fhmg%2Fddw073&rft_id=info%3Apmid%2F26962150&rft.externalDBID=PMC5062587 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0964-6906&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0964-6906&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0964-6906&client=summon |